HIV-1 envelope glycoprotein
Patent
·
OSTI ID:1376215
The present application relates to novel HIV-1 envelope glycoproteins, which may be utilized as HIV-1 vaccine immunogens, and antigens for crystallization, electron microscopy and other biophysical, biochemical and immunological studies for the identification of broad neutralizing antibodies. The present invention encompasses the preparation and purification of immunogenic compositions, which are formulated into the vaccines of the present invention.
- Research Organization:
- Argonne National Laboratory (ANL), Argonne, IL (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC02-06CH11357
- Assignee:
- INTERNATIONAL AIDS VACCINE INITIATIVE
- Patent Number(s):
- 9,738,688
- Application Number:
- 14/072,209
- OSTI ID:
- 1376215
- Resource Relation:
- Patent File Date: 2013 Nov 05
- Country of Publication:
- United States
- Language:
- English
Similar Records
HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees
Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins
Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies
Journal Article
·
Wed Mar 28 00:00:00 EDT 2018
· Journal of Virology
·
OSTI ID:1376215
+19 more
Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins
Journal Article
·
Fri Mar 30 00:00:00 EDT 2007
· Virology
·
OSTI ID:1376215
+14 more
Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies
Journal Article
·
Thu Oct 07 00:00:00 EDT 2010
· PLoS Computational Biology (Online)
·
OSTI ID:1376215
+14 more